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cases of aortoesophageal fistula caused by corrosive ingestion are
reported in the literature.
In cases of surgically repaired aortoesophageal fistulas reported in
the literature,2,3 suture or prosthetic graft replacement of the aorta did
not prove to be an adequate treatment because death from secondary
hemorrhage often occurred because of late dehiscence and reopening
of the aortic breach. The first case of aortoesophageal fistula repair
with an endovascular stent graft was reported by Kato and associates 4
in 2000. In this case the fistula was caused by irradiation of an
esophageal cancer, and therefore intervention was palliative. In our
case the aim was a definitive and minimally invasive treatment in a
critically ill young man with impending coagulopathy. Endovascular
treatment after primary repair of the laceration in the esophagus and
in the aorta and after extensive debridement was the only way to
definitively treat this condition while avoiding further surgical stress
to the patient. In our case the infective risk for the endoprosthesis was
minimal because of preoperative broad-spectrum antibiotic therapy
and deployment of the graft inside an intact aortic wall. Successful
surgical treatment of aortoesophageal fistulas caused by corrosive
injury is rarely reported in the literature, and no cases of endovascular
repair of this condition have been reported. Because surgical treat-
ment alone is not able to result in a definitive solution, endovascular
repair of the fistula and strengthening of malacic aortic walls by
means of a stent graft can be a life-saving and successful approach.
Further experience and follow-up will eventually confirm this result.
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Primary pulmonary artery angiosarcoma (PAS) is a rare,aggressive, and often fatal tumor of the main pulmonaryartery that was first described by Mandelstamm1 in 1923.Only around 200 histologically confirmed incidences2 of
PAS have been documented in the literature to date. The origin of
these angiosarcomas is still uncertain, although characteristically
they arise from pluripotent intimal cells possibly through the
malignant development of intimal/subintimal myofibroblasts.3 These
thoracic sarcomas generally arise from the pulmonary trunk,
spreading to the main or proximal pulmonary arteries, with occa-
sional involvement of the pulmonary valve. The diagnosis is
clinically difficult to distinguish from chronic thromboembolic
pulmonary hypertensive (CTEPH) disease owing to the similarity
of symptoms at presentation. We describe our experience in a
single institution.
Clinical Summary
Since 1988 we have treated 9 patients (5 female) with PAS whose
ages ranging from 26 to 73 years (mean 44 years). Early in the
series, 1 patient had a pneumonectomy and another had a heart-
lung transplant. Since 1999, of 250 patients undergoing pulmonary
thromboendarterectomy (PTE), 6 have undergone attempted PTE
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Figure 2. Postoperative computed tomographic scan showing
correct positioning of the endoprosthesis and reduction in inflam-
mation of mediastinal fat tissue.
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for PAS. One patient was scheduled for surgery but died 1 day
preoperatively. A diagnosis of PAS was made post mortem.
All patients were in New York Heart Association class IV preop-
eratively except for 2 who were in class II. Mean pulmonary artery
pressure preoperatively was 82/34 mm Hg (mean 51 mm Hg), mean
cardiac index was 1.9, and pulmonary vascular resistance was
1115 dynes · s · cm5. A definitive diagnosis of PAS was not made
until during the operation in all cases, although there was a high
index of clinical suspicion in the last 4 patients in the series.
Factors suggestive of PAS rather than CTEPH were rapid progres-
sion of symptoms, absence of a history of deep vein thrombosis,
failure of resolution with thrombolysis in acute cases, and central
occlusion on computed tomographic imaging, in particular, in-
volvement of the pulmonary valve and pulmonary trunk (Figures 1
and 2). However, these can all occur in CTEPH, making the
diagnosis extremely difficult.
In the 6 patients undergoing attempted PTE, surgery was per-
formed under hypothermic (18°C) cardiopulmonary bypass. There
was 1 concomitant pulmonary valve replacement. The mean by-
pass time was 333 minutes and crossclamp time, 82 minutes.
Intermittent circulatory arrest was required in 3 patients (mean 19
minutes).
There were 3 perioperative deaths. The patient receiving a
heart-lung transplant died at 145 days of disseminated metas-
tases, possibly exacerbated by immunosuppression. The 3 sur-
vivors of PTE are alive 142, 428, and 1298 days after the
operation. The patient who had a pneumonectomy has been lost
to follow-up.
Discussion
Because of the difficulty with diagnosis, the most commonly
described surgical intervention is PTE, this being the optimal
procedure for CTEPH disease. Although unlikely to prove curative
in PAS, it does provide the best route to palliation by disobliter-
ating the pulmonary tree and hence relieving the primary cause of
symptoms. Studies have also demonstrated that adjuvant chemo-
therapy or radiotherapy can improve mean survival times by at
least 2- to 3-fold.4
Although initially postulated, pneumonectomy is unlikely to
provide adequate clearance of PAS. These tumors generally arise
from the pulmonary trunk, extending more distally and occasion-
ally bilaterally; hence, unless combined with further surgery to
resect the more central lesion, pneumonectomy alone would be
less than ideal. In fact, it may even exacerbate the degree of right
heart failure that inevitably accompanies such obstructive lesions.
There is only 1 previously described case of heart-lung trans-
plantation for PAS.5 However, as in our case, even this approach
did not allow satisfactory eradication of tumor, since after death
due to secondary infection at 4 months, autopsy still identified
evidence of metastatic disease.
In conclusion, PAS is a rare and aggressive tumor of the
pulmonary vasculature, in which diagnostic differentiation from
CTEPH may prove difficult and may be delayed owing to the
similarity of their characteristic symptoms. Early surgical inter-
vention with possible coadjuvant irradiation or chemotherapy
might allow significant palliation and improve quality of life for
these patients.
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Figure 1. Computed tomographic scan showing central occlusive
material within pulmonary trunk, as well as both left and right
main pulmonary arteries.
Figure 2. Resected pulmonary artery sarcoma specimen.
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